title: Incidence of end stage renal disease on renal replacement therapy in Nepal.
abstract: BACKGROUND
  End stage renal disease patients are treated with dialysis in Nepal. But there is no renal registry to indicate the burden of disease in the country.
  
  
  OBJECTIVE
  The objective of this study is to find out the incidence of ESRD on renal replacement therapy and their out come.
  
  
  METHODS
  It is a retrospective analysis (audit) of all ESRD patients who had received dialysis inside Nepal and had under gone transplantation from 1990 to 1999. The haemodialysis (HD) registry, HD patients file, intermittent peritoneal dialysis (IPD) registry of Bir Hospital, Shree Birendra Hospital, Tribhuwan University Teaching hospital and National Kidney Center were reviewed. Acute renal failure and acute on chronic renal failure were excluded and the demographic profile, dialysis session, dialysis duration and outcome of all ESRD patients were computed. One patient was counted only once in spite of attending more than one center for dialysis. SPSS package was used for analysis.
  
  
  RESULTS
  Total number of 1393 ESRD patients received renal replacement therapy (RRT) in the decade. Mean age of patients were 46.7 +/- 16.7 with 70% of ESRD were between 20-60 years age with male: female ratio of 1.8:1. Initial mode of RRT was IPD in 58.2%, HD in 41.7% and pre-emptive transplantation in 0.1% patients. Records of 189 patients could not be found and out of remaining 1208 patients, 85.8% received dialysis for < 3 months, 6% received dialysis for more than a year and 9.5% had undergone kidney transplantation. The incidence of ESRD had increased gradually with 3.4 per million populations (pmp) in 1990 to 11.89 pmp in 1999 with an average annual incidence of 6 pmp and only 0.31% of expected ESRD patients received RRT.
  
  
  CONCLUSIONS
  The incidence of ESRD is increasing but majority discontinue or die within 3 months. Dialysis centers needs to be expanded to different parts of country and prospective studies have to be carried out to fi nd out of cause of ESRD and to institute preventive measures.
authors.affiliation: National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal. rajani.hada@hotmail.com
authors.forename: Rajani
authors.initials: R
authors.lastname: Hada
authors.forename: S
authors.initials: S
authors.lastname: Khakurel
authors.forename: R K
authors.initials: RK
authors.lastname: Agrawal
authors.forename: R K
authors.initials: RK
authors.lastname: Kafle
authors.forename: S B
authors.initials: SB
authors.lastname: Bajracharya
authors.forename: K B
authors.initials: KB
authors.lastname: Raut
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009390:Nepal / Q000453:epidemiology; D011379:Prognosis; D017582:Renal Replacement Therapy / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D055815:Young Adult